A non-invasive test for stria vascularis dysfunction

Neil J Ingham1, Clarisse H Panganiban1, Carolyn M McClaskey2

  • 1Wolfson Sensory Pain and Regeneration Centre, King's College London, London SE1 1UL, UK.

Hearing Research
|May 20, 2026
PubMed

Insights

A new non-invasive hearing test accurately identifies stria vascularis dysfunction in mice. This auditory brainstem response coherence method could guide human treatments for age-related hearing loss.

Area of Science:

  • Oto-neurology
  • Auditory Neuroscience
  • Medical Diagnostics

Background:

  • Age-related hearing loss (presbycusis) is a prevalent, heterogeneous condition.
  • Key sites of dysfunction include sensory hair cells, neural pathways, and the stria vascularis.
  • The stria vascularis maintains endolymph and endocochlear potential crucial for hearing.

Purpose of the Study:

  • To develop a diagnostic tool for stratifying age-related hearing loss causes.
  • To differentiate stria vascularis dysfunction from sensory or neural deficits.
  • To identify individuals who would benefit from stria vascularis-targeted therapies.

Main Methods:

  • Utilized a panel of well-characterized mouse mutants with known primary sites of hearing dysfunction.
  • Developed a non-invasive auditory brainstem response (ABR) test.
  • Assessed inter-trial coherence of ABRs in response to individual stimuli.

Main Results:

  • Mice with stria vascularis dysfunction exhibited high inter-trial coherence relative to response amplitude.
  • Mice with sensory hair cell or neural deficits showed poor inter-trial coherence.
  • The ABR coherence test successfully distinguished stria vascularis dysfunction from other deficits.

Conclusions:

  • A novel ABR coherence test can non-invasively diagnose stria vascularis dysfunction.
  • This method may predict suitability for treatments targeting stria vascularis function in humans.
  • Improved diagnostics can personalize interventions for age-related hearing loss.